» Articles » PMID: 26627317

Retrograde Pedal Access and Endovascular Revascularization: A Safe and Effective Technique for High-Risk Patients with Complex Tibial Vessel Disease

Overview
Journal Ann Vasc Surg
Publisher Elsevier
Date 2015 Dec 3
PMID 26627317
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Endovascular revascularization is an established approach for limb salvage in the setting of critical limb ischemia. However, failure rate of antegrade recanalization in complex femoropopliteal to infrapopliteal occlusions is as high as 20%. We report a series of 21 patients who underwent retrograde pedal access and recanalization of below-the-knee chronic total occlusions after failed antegrade attempts.

Methods: This is a retrospective review of prospectively maintained data for all patients who underwent ultrasound-guided percutaneous pedal access for retrograde endovascular treatment of advanced tibial vessel disease between 2011 and 2014. All patients had undergone prior unsuccessful attempts at antegrade revascularization. Pedal vessel access was followed by angioplasty with selective stenting and completion angiogram. Patients were followed up with duplex ultrasound to evaluate for patency. Time-dependent outcomes were determined by Kaplan-Meier survival analyses. Median follow-up was 9 months.

Results: A total of 21 patients (17 men, 4 women, mean age 68) underwent retrograde tibial recanalization. Eighty-one percent of the patients presented with Rutherford category 4, 5, or 6 critical limb ischemia. The average Prevent III amputation risk score was 7.0 ± 2.9. Eighteen patients (86%) were medium or high risk (Prevent III amputation risk score ≥ 4). Retrograde pedal access was successful in 95% of the patients (dorsalis pedis = 11, posterior tibial = 5, anterior tibial = 4). Retrograde revascularization was achieved in 14 patients (67%) using balloon angioplasty (n = 14) and additional stent placement (n = 2). Revascularization failed in 7 patients (33%). There were no pedal access site complications. Forty-eight percent of the patients experienced improvement or resolution of their symptoms. The 30-day major adverse cardiac events (MACE), major adverse limb events (MALE), and amputations were all 5%. At 1 year, limb salvage was 88 ± 8% with amputation-free survival of 61 ± 12% and freedom from MALE of 81 ± 10%. Primary assisted and secondary patencies were both 84 ± 10% at 1 year.

Conclusions: Early outcomes for ultrasound-guided retrograde pedal access show that it is safe, with low 30-day mortality, and a low rate of MACE. Freedom from MALE and limb salvage are both high at 1-year follow-up. This technique expands revascularization options after failed conventional endovascular antegrade approaches.

Citing Articles

Role of Retrograde Tibiopedal Access in Limb Salvage in Patients with Critical Lower Limb Ischemia.

Ghoneim B, Elhindawy K, Fouad F, Ellil M, Shaker A Int J Angiol. 2025; 34(1):33-38.

PMID: 39944149 PMC: 11813600. DOI: 10.1055/s-0044-1786857.


Ultrasound-guided retrograde tibial access through chronically occluded tibial arteries: a last resort recanalization technique.

Aygun M, Tureli D, Deniz S, Oguzkurt L Diagn Interv Radiol. 2022; 28(6):621-626.

PMID: 36550764 PMC: 9885662. DOI: 10.5152/dir.2022.21844.


State-of-the-Art Endovascular Therapies for the Femoropopliteal Segment: Are We There Yet?.

Mosarla R, Armstrong E, Bitton-Faiwiszewski Y, Schneider P, Secemsky E J Soc Cardiovasc Angiogr Interv. 2022; 1(5).

PMID: 36268042 PMC: 9581461. DOI: 10.1016/j.jscai.2022.100439.


Trans-pedal access for endovascular revascularization in complex infra-popliteal lesions in critically ischemic limb: A cohort study.

AbdelGawad M, Wahba A, Elshafie A, Abdelnaby M, Mowafy K Ann Med Surg (Lond). 2022; 81:104215.

PMID: 36147135 PMC: 9486428. DOI: 10.1016/j.amsu.2022.104215.


Pediatric abdominal arterial intervention using a steerable microcatheter through an introducer with 4-F outer diameter: report of two cases.

Onishi Y, Ohno T, Shimizu H, Hiramatsu H, Yokoyama A, Okamoto T Radiol Case Rep. 2021; 16(11):3326-3329.

PMID: 34484540 PMC: 8403709. DOI: 10.1016/j.radcr.2021.07.095.